Virtus ETF Advisers LLC - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 85 filers reported holding UNITY BIOTECHNOLOGY INC in Q2 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q1 2020$249,000
-29.9%
43,010
-12.7%
0.10%
+75.9%
Q4 2019$355,000
+100.6%
49,283
+70.3%
0.06%
+61.1%
Q3 2019$177,000
-39.0%
28,942
-5.3%
0.04%
-41.0%
Q2 2019$290,000
+116.4%
30,554
+84.8%
0.06%
-78.6%
Q1 2019$134,000
-56.6%
16,533
-12.9%
0.28%
+437.7%
Q4 2018$309,00018,9870.05%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q2 2020
NameSharesValueWeighting ↓
Mayo Clinic 1,571,981$9,117,00023.05%
Invus Financial Advisors, LLC 2,189,998$12,702,0006.24%
Leap Investments LP 13,400$78,0000.11%
Moloney Securities Asset Management, LLC 51,950$301,0000.11%
Verity Asset Management, Inc. 14,748$86,0000.11%
Virtus ETF Advisers LLC 43,010$249,0000.10%
Investors Financial Group, LLC 15,850$92,0000.09%
SUNFLOWER BANK, NA WEALTH MANAGEMENT 20,000$116,0000.04%
Baillie Gifford 3,803,014$22,057,0000.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 315,047$1,827,0000.02%
View complete list of UNITY BIOTECHNOLOGY INC shareholders